Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-03

Clinical Trial Update: Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of azimilide dihydrochloride in patients with cardiac arrhythmias treated with implantable cardioverter-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azimilide dihydrochloride (azimilide dihydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Arrhythmia | Phase 3 | Status: COMPLETED